SEGMENT INFORMATION

6 Months Ended

Jun. 30, 2015

Segment Reporting [Abstract]

Segment Reporting Disclosure [Text Block]

NOTE 7:- SEGMENT INFORMATION

a. The following segment identification is identical to the segment used in the latest annual consolidated financial report.

b. The following presents segment results of operations for the six months ended June 30, 2015 (unaudited):

	Cellocator segment		MRM segment		RSA segment		Elimination			Total
Segments revenues	$	11,009	$	22,484	$	17,663	$	(869	)	$	50,287
Segments operating profit	$	1,243	$	1,717	$	592	$	159		$	3,711
Segments tangible and intangible assets	$	8,758	$	26,926	$	22,172	$	3,620		$	61,476
Depreciation and amortization	$	171	$	1,175	$	639	$	-		$	1,985
Expenditures for assets	$	79	$	906	$	369	$	-		$	1,354

c. The following presents segment results of operations for the six months ended June 30, 2014 (unaudited):

	Cellocator segment		MRM segment		RSA segment		Elimination			Total
Segments revenues	$	11,265	$	28,914	$	18,041	$	(5,331	)	$	52,889
Segments operating profit (loss)	$	1,517	$	4,778	$	768	$	(2,826	)	$	4,237
Segments tangible and intangible assets	$	9,468	$	30,278	$	20,607	$	5,434		$	71,787
Depreciation, amortization and impairment expenses	$	177	$	1,347	$	951	$	-		$	2,475
Expenditures for assets	$	104	$	1,730	$	414	$	-		$	2,248

d. The following presents segment results of operations for the three months ended June 30, 2015 (unaudited):

	Cellocator segment		MRM  segment		RSA segment		Elimination			Total
Segments revenues	$	5,545	$	11,124	$	8,921	$	(280	)	$	25,310
Segments operating profit	$	612	$	730	$	244	$	55		$	1,641
Segments tangible and intangible assets	$	8,758	$	26,926	$	22,172	$	3,620		$	61,476
Depreciation and amortization	$	85	$	584	$	310	$	-		$	979
Expenditures for assets	$	50	$	466	$	253	$	-		$	769

e. The following presents segment results of operations for the three months ended June 30, 2014 (unaudited):

	Cellocator segment		MRM  segment		RSA segment		Elimination			Total
Segments revenues	$	5,867	$	13,886	$	9,122	$	(3,001	)	$	25,874
Segments operating profit (loss)	$	933	$	900	$	263	$	(426	)	$	1,670
Segments tangible and intangible assets	$	9,468	$	30,278	$	20,607	$	5,434		$	71,787
Depreciation, amortization and impairment expenses	$	89	$	628	$	477	$	-		$	1,194
Expenditures for assets	$	72	$	739	$	283	$	-		$	1,094

f. The following presents segment results of operations for the year ended December 31, 2014:

	Cellocator segment		MRM segment		RSA segment			Elimination			Total
Segments revenues	$	24,063	$	55,911	$	36,168		$	(10,852	)	$	105,290
Segments operating profit (loss)	$	3,859	$	5,619	$	(60	)	$	(2,871	)	$	6,547
Segments tangible and intangible assets	$	8,679	$	26,878	$	22,038		$	4,405		$	62,000
Depreciation, amortization and impairment expenses	$	349	$	2,188	$	2,230		$	-		$	4,767
Expenditures for assets	$	165	$	2,586	$	1,706		$	-		$	4,457